Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Venous Thrombosis

• RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
• Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
• A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis
• H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis
• Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis
• DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
• Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
• Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects
• Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
• Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer
• Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.
• Clinical Study on the Efficacy and Safety of Multiple Oral Administrations of SHR2285 Tablets in Patients Undergoing Elective Total Knee Arthroplasty
• A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
• A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
• HAIC Combine With Lenvatinib and Camrelizumab for Advanced HCC With PVTT
• Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures
• The API-CALF Study: Apixaban to Treat Calf Vein Thrombosis
• Safety of Anticoagulant Therapy After Variceal Band Ligation
• Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis
• Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
• Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis
• Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome
• Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis
• Pre- vs Postoperative Thromboprophylaxis for Liver Resection
• Optimal Duration of Anticoagulation Therapy for Low-risk Pulmonary Embolism Patients With Cancer
• Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting
• Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis
• Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
• Rivaroxaban vs. Warfarin in CVT Treatment
• Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis
• Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
• Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis
• Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19
• Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
• Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
• COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
• Prophylactic Anticoagulation for Catheter-related Thrombosis
• Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis
• Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban
• Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism
• Diagnostic Validity of [18F]GP1 PET for Diagnosing Acute Deep Vein Thrombosis
• Aspirin® Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis in Patients With PTS
• Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study
• Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis
• Phase I Study of Direct Coagulation Factor Xa Inhibitor SYHA136 Tablets in Chinese Healthy Volunteers
• PET Fibrin Imaging of DVT and PE
• Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study
• Screening for Cancer in Patients With Thromboembolic Disease
• Optimal Duration of Anticoagulation Therapy for Isolated Distal Deep Vein Thrombosis in Patients With Cancer Study
• Dose Effect of Tranexamic Acid on the Incidence of Deep Venous Thrombus in Cardiac Surgery
• Below Knee DVT Study
• Selective Thromboembolism Prophylaxis After Arthroplasty
• Efficacy Comparison of Warfarin Versus Rivaroxaban CVT
• The Effect of Rifaximin on Portal Vein Thrombosis
• Calf Deep Vein Thrombosis Treatment Trial
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin
• Thromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines
• PeriOperative ISchemic Evaluation-3 Trial
• Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis
• TIPS or Anticoagulation in Portal Vein Thrombosis
• Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis
• Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
• Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin
• Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients
• A Study of Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism
• The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis
• Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery
• Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV
• Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis
• Study of Rivaroxaban for CeREbral Venous Thrombosis
• The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
• Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy
• Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism
• Outcomes Study in Patients Receiving Aspirin With Mechanical Compression Devices Versus Aspirin Alone Following Knee and Hip Arthroplasty
• Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosis
• PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
• Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial
• Leiden Trial In Prevention of Post-Operative ThromboEmbolic Events
• Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin
• Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis
• Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.
• Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
• Tranexamic Acid and Blood Clots in Knee Surgery
• TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
• Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
• Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
• Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial
• Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)
• Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
• A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer
• Rivaroxaban for the Treatment of Symptomatic Isolated Distal Deep Vein Thrombosis
• Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses
• Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.
• Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose
• INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis
• Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery Patients
• Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
• The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT
• Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study
• Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial
• Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
• Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
• Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
• Bioequivalence Study of Rivaroxaban
• Bioequivalence Study of Rivaroxaban in Japanese Healthy Adult Male Subjects
• Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
• XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
• Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study
• TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
• Evaluation of a New Imagingtechnologie for Thrombosis
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)
• Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
• Enoxaparin Metabolism in Reconstructive Surgery Patients
• The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis
• Prophylaxis of Deep Vein Thrombosis Following Total Hip Arthroplasty
• The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
• A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries
• Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico
• Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
• Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
• EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis
• Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study
• Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy
• Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis
• Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
• Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
• Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
• Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
• Rivaroxaban Anticoagulation for Superficial Vein Thrombosis
• Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty
• Cancer Venous Thromboembolism (VTE)
• Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis
• Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)
• Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
• Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)
• Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
• Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT
• Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)
• Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
• Anticoagulation Length in Cancer Associated Thrombosis
• Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy
• Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication
• AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients
• Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
• ARIXTRA® Adherence in SVT Patients.
• Oral Rivaroxaban in Children With Venous Thrombosis
• A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis
• Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.
• A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.
• Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver
• Bemiparin as a Thromboprophylaxis After Gynaecological Surgeries
• Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
• Rosuvastatin Use to Improve the Coagulation Profile in Patients With Venous Thrombosis
• Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery
• PREvention of VENous Thromboembolism In Hemorrhagic Stroke Patients
• Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation
• Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy
• Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)
• Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
• Switching Study From Warfarin to Rivaroxaban
• Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux
• Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery
• Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
• Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
• Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin
• A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting
• Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients
• Study Of Lybrel In Relation To Venous Thromboembolism
• Optimal Duration of Anticoagulation in Deep Venous Thrombosis
• Two Weeks of Low Molecular Weight Heparin for Distal Vein Thrombosis
• Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis
• Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
• A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty
• Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis
• Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
• Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
• Drug Interaction Between Paracetamol and Warfarin
• Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
• Hemorrhage Risk Prescribed Arixtra
• Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users
• Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
• Rosuvastatin for Preventing Deep Vein Thrombosis
• Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).
• VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management
• Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer
• The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
• D-Dimer Guided Oral Anticoagulant Treatment (OAT)
• Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
• Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures
• Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.
• A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
• Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)
• The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids
• Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis
• Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
• A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
• Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
• Anticoagulation Post Laparoscopic Splenectomy
• Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)
• Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis
• Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study
• Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
• Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer
• Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities
• Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
• Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation
• Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid
• Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT
• Birth Control Pill vs Birth Control Patch Study
• Study of Arixtra (Fondaparinux Sodium) to Prevent Blood Clots in Women Undergoing Abdominopelvic Surgery for Likely Gynecologic Malignancy
• Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients
• Atorvastatin for the Treatment of Retinal Vein Occlusion
• Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
• Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients
• Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
• Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis
• Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
• Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study
• Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
• Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
• Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
• Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
• Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)
• Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
• Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism
• Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
• Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis
• Ultrasound Findings to Adjust the Duration of Anticoagulation
• Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
• 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE
• Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis
• Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)
• Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
• The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients
• EVENT: Hydrotherapy and Deep Venous Thrombosis
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters
• Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
• A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"
• Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery
• Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters
• Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
• VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
• Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
• Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs
• Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery
• Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis
• Enoxaparin in Acute Venous Thromboembolic Disease
• D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism
• Oral Direct Factor Xa-inhibitor Apixaban in Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study
• A Study of BIBR 1048 in Prevention of Venous Thromboembolism in Patients With TKR Surgery.
• Treatment of Upper Extremity Deep-Vein Thrombosis
• Odiparcil For The Prevention Of Venous Thromboembolism
• The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation.
• The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section
• Aspirin for the Prevention of Recurrent Venous Thromboembolism
• The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis
• A Study to Confirm the Safety and Efficacy of Epoetin Alfa (PROCRIT) Administered Perioperatively vs. the Standard of Care in Blood Conservation in Patients Undergoing Major Elective Spinal Surgery (SPINE Study)
• Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin
• Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)
• The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial
• Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
• Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
• Fixed Dose Heparin Study
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot)
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)
• The Use of Low Molecular Weight Heparin in Traumatic Brain Injury
• Genetic Determinants of Warfarin Anticoagulation Effect
• Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis
• BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
• Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins
• SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis
• Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)
• Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients
• Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis